Home  » Topic

Aurobindo Pharma News


HDFC MF-Backed Bluechip Stock To Turn Ex-Dividend On Monday For 300%: Buy?
With a market valuation of Rs 59,033.31 Cr, Aurobindo Pharma Ltd is a blue-chip company in the healthcare industry. Apart from dominating the Semi-Synthetic Penicillin market, it is also present in key therapeutic areas including anti-biotics, gastroenterology, anti-retrovirals, neurosciences, and cardiology. ...
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X